SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Frank Konings¹, Mark D Perkins², Jens H Kuhn³, Mark J Pallen⁴, Erik J Alm⁵, Brett N Archer¹, Amal Barakat¹, Trevor Bedford⁶, Jinal N Bhiman^{7

8}, Leon Caly⁹, Lisa L Carter¹, Anne Cullinane¹⁰, Tulio de Oliveira¹¹, Julian Druce⁹, Ihab El Masry¹², Roger Evans¹, George F Gao¹³, Alexander E Gorbalenya^{14

15}, Esther Hamblion¹, Belinda L Herring¹, Emma Hodcroft¹⁶, Edward C Holmes¹⁷, Manish Kakkar¹, Shagun Khare¹, Marion P G Koopmans¹⁸, Bette Korber¹⁹, Juliana Leite¹, Duncan MacCannell²⁰, Marco Marklewitz¹, Sebastian Maurer-Stroh^{21

22}, Jairo Andres Mendez Rico¹, Vincent J Munster²³, Richard Neher²⁴, Bas Oude Munnink¹⁸, Boris I Pavlin¹, Malik Peiris²⁵, Leo Poon²⁵, Oliver Pybus²⁶, Andrew Rambaut²⁷, Paola Resende²⁸, Lorenzo Subissi¹, Volker Thiel^{16

29}, Suxiang Tong²⁰, Sylvie van der Werf³⁰, Anne von Gottberg^{7

8}, John Ziebuhr³¹, Maria D Van Kerkhove¹

Affiliations

¹ World Health Organization, Geneva, Switzerland.
² World Health Organization, Geneva, Switzerland. perkinsm@who.int.
³ Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA.
⁴ Quadram Institute Bioscience, University of East Anglia, Norwich, UK.
⁵ European Centre for Disease Prevention and Control, Stockholm, Sweden.
⁶ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁷ National Institute for Communicable Diseases, Johannesburg, South Africa.
⁸ School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
⁹ Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne, Victoria, Australia.
¹⁰ Faculty of Science and Engineering, University of Limerick, Limerick, Ireland.
¹¹ University of KwaZulu-Natal, Durban, South Africa.
¹² Emergency Centre for Transboundary Animal Disease, Food and Agriculture Organization of the United Nations (FAO), Cairo, Egypt.
¹³ Chinese Center for Disease Control and Prevention, Beijing, P.R. China.
¹⁴ Leiden University Medical Center, Leiden, The Netherlands.
¹⁵ Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
¹⁶ University of Bern, Bern, Switzerland.
¹⁷ The University of Sydney, Sydney, New South Wales, Australia.
¹⁸ Erasmus University, Rotterdam, The Netherlands.
¹⁹ Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.
²⁰ United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
²¹ The Global Initiative on Sharing All Influenza Data (GISAID), Munich, Germany.
²² Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore.
²³ Virus Ecology Unit, National Institute of Allergy and Infectious Diseases, Rockville, MA, USA.
²⁴ Biozentrum, University of Basel, Switzerland Swiss Institute of Bioinformatics, Basel, Switzerland.
²⁵ The University of Hong Kong, Hong Kong, China.
²⁶ University of Oxford, Oxford, United Kingdom.
²⁷ Institute for Evolutionary Biology, Ashworth Laboratories, University of Edinburgh, Edinburgh, UK.
²⁸ Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
²⁹ Institute of Virology and Immunology, Mittelhäusern, Switzerland.
³⁰ Institut Pasteur, Paris, France.
³¹ Institute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.

PMID: 34108654
DOI: 10.1038/s41564-021-00932-w

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Frank Konings et al. Nat Microbiol. 2021 Jul.

. 2021 Jul;6(7):821-823.

doi: 10.1038/s41564-021-00932-w.

Authors

Affiliations

¹ World Health Organization, Geneva, Switzerland.
² World Health Organization, Geneva, Switzerland. perkinsm@who.int.
³ Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA.
⁴ Quadram Institute Bioscience, University of East Anglia, Norwich, UK.
⁵ European Centre for Disease Prevention and Control, Stockholm, Sweden.
⁶ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁷ National Institute for Communicable Diseases, Johannesburg, South Africa.
⁸ School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
⁹ Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne, Victoria, Australia.
¹⁰ Faculty of Science and Engineering, University of Limerick, Limerick, Ireland.
¹¹ University of KwaZulu-Natal, Durban, South Africa.
¹² Emergency Centre for Transboundary Animal Disease, Food and Agriculture Organization of the United Nations (FAO), Cairo, Egypt.
¹³ Chinese Center for Disease Control and Prevention, Beijing, P.R. China.
¹⁴ Leiden University Medical Center, Leiden, The Netherlands.
¹⁵ Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
¹⁶ University of Bern, Bern, Switzerland.
¹⁷ The University of Sydney, Sydney, New South Wales, Australia.
¹⁸ Erasmus University, Rotterdam, The Netherlands.
¹⁹ Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.
²⁰ United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
²¹ The Global Initiative on Sharing All Influenza Data (GISAID), Munich, Germany.
²² Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore.
²³ Virus Ecology Unit, National Institute of Allergy and Infectious Diseases, Rockville, MA, USA.
²⁴ Biozentrum, University of Basel, Switzerland Swiss Institute of Bioinformatics, Basel, Switzerland.
²⁵ The University of Hong Kong, Hong Kong, China.
²⁶ University of Oxford, Oxford, United Kingdom.
²⁷ Institute for Evolutionary Biology, Ashworth Laboratories, University of Edinburgh, Edinburgh, UK.
²⁸ Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
²⁹ Institute of Virology and Immunology, Mittelhäusern, Switzerland.
³⁰ Institut Pasteur, Paris, France.
³¹ Institute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.

PMID: 34108654
DOI: 10.1038/s41564-021-00932-w

No abstract available

PubMed Disclaimer

Comment in

Embrace the WHO's new naming system for coronavirus variants.
[No authors listed] [No authors listed] Nature. 2021 Jun;594(7862):149. doi: 10.1038/d41586-021-01508-8. Nature. 2021. PMID: 34108702 No abstract available.

References

1. WHO reference laboratories providing confirmatory testing for COVID-19. WHO https://go.nature.com/3ySxqX3 (2020).
1. COVID-19 weekly epidemiological update – 25 February 2021. WHO https://go.nature.com/3uEtXIj (2021).
1. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. WHO https://go.nature.com/3aahjbg (2021).
1. Clade and lineage nomenclature aids in genomic epidemiology studies of active hCoV-19 viruses. GISAID https://go.nature.com/3pgSIt6 (2021).
1. Bedford, T., Hodcroft, E. B. & Neher, R. A. Updated Nextstrain SARS-CoV-2 clade naming strategy. Nextstrain https://go.nature.com/3c9Riep (2021).

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Affiliations

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Authors

Affiliations

Comment in

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous